EUROPEAN 
COMMISSION 
Brussels, XXX 
[...](2014) XXX draft 
COMMISSION REGULATION (EU) No 
of XXX 
amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council 
on classification, labelling and packaging of substances and mixtures, for the purposes of 
its adaptation to technical and scientific progress, and Commission Regulation (EU) No 
605/2014 amending for the purposes of introducing hazard and precautionary 
statements in the Croatian language and its adoption to technical and scientific progress, 
Regulation (EC) No 1272/2008 of the European Parliament and of the Council on 
classification, labelling and packaging of substances and mixtures 
(Text with EEA relevance) 
EN EN COMMISSION REGULATION (EU) No ..J€ 
of XXX 
amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council 
on classification, labelling and packaging of substances and mixtures, for the purposes of 
its adaptation to technical and scientific progress, and Commission Regulation (EU) No 
605/2014 amending for the purposes of introducing hazard and precautionary 
statements in the Croatian language and its adoption to technical and scientific progress, 
Regulation (EC) No 1272/2008 of the European Parliament and of the Council on 
classification, labelling and packaging of substances and mixtures 
(Text with EE A relevance) 
THE EUROPEAN COMMISSION, 
Having regard to the Treaty on the Functioning of the European Union, 
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the 
Council of 16 December 2008 on classification, labelling and packaging of substances and 
mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending 
Regulation (EC) No 1907/2006\ and in particular Article 37(5) thereof, 
Whereas: 
(1) Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised 
classification and labelling of hazardous substances. Table 3.1 lists the harmonised 
classification and labelling of hazardous substances based on the criteria set out in 
Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the 
harmonised classification and labelling of hazardous substances based on the criteria 
set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the 
approximation of laws, regulations and administrative provisions relating to the 
classification, packaging and labelling of dangerous substances2. 
(2) Proposals for new or updated harmonised classification and labelling of certain 
substances have been submitted to the European Chemicals Agency (ECHA) pursuant 
to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those 
proposals issued by the Committee for Risk Assessment of ECHA, as well as on the 
comments received from the parties concerned, it is appropriate to introduce or update 
harmonised classification and labelling of certain substances by amending Annex VI 
to that Regulation. 
(3) With regard to the substance nitric acid ... % (EC number : 231-714-2), new scientific 
data has been made available for the hazard class 'acute toxicity' which suggests that 
the classification for this hazard class as recommended in the RAC opinion, which is 
based on older data, might not be appropriate. Therefore, this hazard class should not 
be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has issued an 
OJL353, 31.12.2008,p.l. 
OJL 196, 16.8.1967, p. 1. 
EN 2 EN opinion on the new information, while all other classes covered by the earlier opinion 
should be included. 
(4) With regard to the substance phenol, dodecyl-, branched (EC number : 310-154-3), 
the RAC is in the process of adopting a new opinion for the specific concentration 
limits to be applied to the hazard class 'toxic for reproduction'. Therefore, this hazard 
class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that 
opinion is finalised. 
(5) Compliance with the new harmonised classifications should not be required 
immediately, as a certain period of time will be necessary to allow suppliers to adapt 
the labelling and packaging of substances and mixtures to the new classifications and 
to sell existing stocks. In addition, a certain period of time will be necessary to allow 
suppliers to comply with the registration obligations resulting from the new 
harmonised classifications for substances classified as carcinogenic, mutagenic or 
toxic to reproduction, categories 1A and IB (Table 3.1) and categories 1 and 2 (Table 
3.2), or as very toxic to aquatic organisms which may cause long term effects in the 
aquatic environment, in particular with those set out in Article 23 of Regulation (EC) 
No 1907/2006 of the European Parliament and of the Council of 18 December 2006 
concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH), establishing a European Chemicals Agency, amending Directive 
1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission 
Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and 
Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC3. 
(6) In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow 
the application of the new provisions at an earlier stage on a voluntary basis, suppliers 
should have the possibility of applying the new harmonised classifications and of 
adapting the labelling and packaging accordingly on a voluntary basis before the 
deadline for compliance. 
(7) Commission Regulation (EU) No 605/20144 was adopted on 5 June 2014 and provides 
for the application of new or updated provisions for harmonised classification and 
labelling of a number of substances as from 1 April 2015. Due to some delays in the 
adoption process of this Regulation, this transitional period is significantly shorter than 
the ones applied for previous adaptations to technical and scientific progress. Ten 
months appear insufficient to allow economic operators to adapt to the new rules, 
some of which affect widely used chemicals. The application date should therefore be 
deferred to 1 January 2016 to allow for a transitional period that is in line with the 
practice in place for previous adaptations to technical progress. 
(8) The measures provided for in this Regulation are in accordance with the opinion of the 
Committee established under Article 133 of Regulation (EC) No 1907/2006, 
HAS ADOPTED THIS REGULATION: 
Article 1 
Regulation (EC) No 1272/2008 is amended as follows: 
Annex VI is amended in accordance with the Annex to this Regulation. 
3 OJ L 396, 30.12.2006, p. 1. 
4 OJL167, 6.6.2014, p.36. 
EN 3 EN Article 2 
By way of derogation from Article 4(2), the harmonised classifications set out in Annex to 
this Regulation may be applied before the date referred to in Article 4(2). 
Article 3 
Article 3(3) of Commission Regulation (EU) No 605/2014 shall be replaced by the following: 
"Article 1(3) shall apply from 1 January 2016." 
Article 4 
1. This Regulation shall enter into force on the twentieth day following that of its 
publication in the Official Journal of the European Union. 
2. Article 1 shall apply in respect of substances and mixtures from 1 July 2016. 
This Regulation shall be binding in its entirety and directly applicable in all Member States. 
Done at Brussels, 
For the Commission 
The President 
[...] 
EN 4 EN EN 
ANNEX 
Part 3 of Annex VI is amended as follows: 
(1) Table 3.1 is amended as follows: 
(a) The entries corresponding to index numbers 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-
7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X, and 613-149-00-7 are replaced by the following 
corresponding entries: 
Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
007-004-00-1 nitric acid... % 231-714-2 7697-37-2 Ox. Liq. 2 
Skin Corr. 1A H272 
H314 GHS03 
GHS05 
Dgr H272 
H314 EUH071 Skin Corr. 1A; 
H314: C > 20 % 
Skin Corr. IB; 
H314: 5 % < C 
<20 % 
Ox. Liq. 2; 
H272: C >99 % 
Ox. Liq. 3; 
H272: 99 % > C 
>65 % В 
015-003-00-2 calcium phosphide; tricalcium 
diphosphide 215-142-0 1305-99-3 Water-react. 1 
Acute Tox. 2 
Acute Tox. 3 
Acute Tox. 1 
Eye Dam. 1 
Aquatic Acute 1 11260 
H300 
H311 
H330 
H318 
H400 GHS02 
GHS06 
GHS05 
GHS09 
Dgr H260 
H300 
H311 
H330 
H318 
H400 EUH029 
EUH032 
M=100 
031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Repr. IB 
Care. IB 
STOT RE 1 H360F 
H350 
H372 
(respiratory 
and 
haematopoietic 
systems) GHS08 
Dgr H360F 
H350 
H372 
(respiratory 
and 
haematopoieti 
c systems) 
1 Index No International Chemical EC No CAS No Classification Labelling Specific Cone. Notes 
Identification 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Limits, M-
factors 
050-008-00-3 tributyltin compounds, with the 
exception of those specified 
elsewhere in this annex - -Repr. IB 
Acute Tox.3 
Acute Tox.-4* 
STOT RE 1 
Skin Irrit. 2 
Eye Irrit. 2 
Aquatic Acute 1 
Aquatic Chronic 1 H360FD 
H301 
H312 
H372** 
H315 
H319 
H400 
H410 GHS08 
GHS06 
GHS09 
Dgr H360FD 
H301 
H312 
H372** 
H315 
H319 
H410 * 
STOT RE 1; 
H372: C > 1 % 
STOT RE 2; 
H373: 0,25 % < 
C<1% 
Skin Irrit. 2; 
H315:C > 1 % 
Eye Irrit. 2; 
H319:C > 1 % 
М=10 А 
1 
603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 Flam. Liq. 2 
Care. 2 
Acute Tox. 4* 
Acute Tox. 4* 
Acute Tox. 4* 
STOT SE 3 
Skin Irrit. 2 
Eye Irrit. 2 H225 
H351 
H302 
H312 
H332 
H335 
H315 
H319 GHS02 
GHS08 
GHS07 
Dgr H225 
H351 
H302 
H312 
H332 
H335 
H315 
H319 
603-197-00-7 tebuconazole (ISO); 
l-(4-chlorophenyl)-4,4-
dimethyl-3-(l,2,4-triazol-l-
ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2 
Acute Tox. 4 
Aquatic Acute 1 
Aquatic Chronic 1 H361d*** 
H302 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H361d*** 
H302 
H410 М=1 
М=10 
606-054-00-7 isoxafiutole (ISO); 5-
cyclopropyl-l,2-oxazol-4-yl 
a,a,a-trffluoro-2-mesyl-p-tolyl 
ketone - 141112-29-0 Repr. 2 
Aquatic Acute 1 
Aquatic Chronic 1 H361d*** 
H400 
H410 GHS08 
GHS09 
Wng H361d*** 
H410 М=10 
М=100 
607-197-00-8 nonanoic acid 203-931-2 112-05-0 Skin Irrit. 2 
Eye Irrit. 2 
Aquatic Chronic 3 H315 
H319 
H412 GHS07 
Wng H315 
H319 
H412 
613-042-00-5 imazalil (ISO); l-[2-(allyloxy)-
2-(2,4-dichlorophenyl)ethyl]-
Ш-imidazole 252-615-0 35554-44-0 Care. 2 
Acute Tox. 3 
Acute Tox. 4 
Eye Dam. 1 
Aquatic Chronic 1 H351 
H301 
H332 
H318 
H410 GHS08 
GHS06 
GHS05 
GHS09 
Dgr H351 
H301 
H332 
H318 
H410 М=10 
2 Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
613-057-00-7 dodemorph (ISO); 4-
cyclododecyl-2,6-
dimethylmorpholine 216-474-9 1593-77-7 Repr. 2 
STOT RE 2 
Skin Corr. 1C 
Skin Sens. 1A 
Aquatic Acute 1 
Aquatic Chronic 1 H361d 
H373 (liver) 
H314 
H317 
H400 
H410 GHS08 
GHS05 
GHS07 
GHS09 
Dgr H361d 
H373 (liver) 
H314 
H317 
H410 EUH071 
M=1 
M=1 
613-133-00-X etridiazole (ISO); 5-ethoxy-3-
trichloromethyl-1,2,4-
thiadiazole 219-991-8 2593-15-9 Care. 2 
Acute Tox. 4 
Skin Sens. 1 
Aquatic Acute 1 
Aquatic Chronic 1 H351 
H302 
H317 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H351 
H302 
H317 
H410 M=1 
M=1 
613-149-00-7 pyridaben (ISO); 
2-tert-butyl-5-(4-tert-
butylbenzylthio)-4-
chloropyridazin-3(2H)-one 405-700-3 96489-71-3 Acute Tox. 3 
Acute Tox. 3 
Aquatic Acute 1 
Aquatic Chronic 1 H331 
H301 
H400 
H410 GHS06 
GHS09 
Dgr H331 
H301 
H410 M=1000 
M=1000 
(b) The following entries are inserted in accordance with the order of the entries set out in Table 3.1: 
Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
019-003-00-3 potassium (E,E)-hexa-2,4-
dienoate 246-376-1 24634-61-5 Eye Irrit. 2 H319 GSH07 
Wng H319 
082-013-00-1 lead 231-100-4 7439-92-1 Repr. 1A 
Lact. H360FD 
H362 GHS08 
Dgr H360FD 
H362 Repr. 1A; 
H360D: C > 0,03 
% 
604- 092-00-9 phenol, dodecyl-, branched [1]; 
phenol, 2-dodecyl-, branched; 
phenol, 3-dodecyl-, branched; 
phenol, 4-dodecyl-, branched; 
phenol, (tetrapropenyl) 
derivatives [2] 310-154-3 
[1] 121158-58-5 
[1] 
74499-35-7 
[2] Skin Corr. 1C 
Aquatic Acute 1 
Aquatic Chronic 1 H314 
H400 
H410 GHS05 
GHS09 
Dgr H314 
H410 M=10 
M=10 
3 Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
606-148-00-8 cervone (ISO); 
2-methyl-5-(prop-l-en-2-
yl)cyclohex-2-en-l-one; [1] 
d-carvone; (5S)-2-methyl-5-
(prop-l-en-2-yl)cyclohex-2-en-
1-one; [2] 
1-carvone; (5R)-2-methyl-5-
(prop-l-en-2-yl)cyclohex-2-en-
1-one [3] 202-759-5 
[1] 
218-827-2 
[2] 
229-352-5 
[3] 99-49-0 [1] 
2244-16-8 [2] 
6485-40-1 [3] Skin Sens. 1 H317 GHS07 
Wng H317 
606-149-00-3 tembotrione (ISO); 2-{2-chloro-
4-(methylsulfonyl)-3-[(2,2,2-
trifluoroethoxy)methyl]benzoył 
}cyclohexane-l,3-dione - 335104-84-2 Repr. 2 
STOT RE 2 
Skin Sens. 1 
Aquatic Acute 1 
Aquatic Chronic 1 H361d 
H373 
(eyes, kidneys, 
liver) 
H317 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H361d 
H373 
(eyes, kidneys, 
liver) 
H317 
H410 
M=100 
M=10 
607-707-00-9 fenoxaprop-P-ethyl (ISO); ethyl 
(2R)-2-{4-[(6-chloro-l,3-
benzoxazol-2-
yl)oxy]phenoxy}propanoate - 71283-80-2 STOT RE 2 
Skin Sens. 1 
Aquatic Acute 1 
Aquatic Chronic 1 H373 (kidneys) 
H317 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H373 
(kidneys) 
H317 
H410 M=1 
M=1 
607-708-00-4 octanoic acid 204-677-5 124-07-2 Skin Corr. 1C 
Aquatic Chronic 3 H314 
H412 GHS05 
Dgr H314 
H412 
607-709-00-X decanoic acid 206-376-4 334-48-5 Skin Irrit. 2 
Eye Irrit. 2 
Aquatic Chronic 3 H315 
H319 
H412 GHS07 
Wng H315 
H319 
H412 
607-710-00-5 1,2-benzenedicarboxylic acid, 
dihexyl ester, branched and 
linear 271-093-5 68515-50-4 Repr. IB H360FD GHS08 
Dgr H360FD 
4 Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
607-711-00-0 spirotetramat (ISO); (5s,8s)-3-
(2,5-dimethylphenyl)-8-
methoxy-2-охо-1 -
azaspiro[4,5]dec-3-tn-4-yi ethyl 
carbonate - 203313-25-1 Repr. 2 
STOT SE 3 
Eye Irrit. 2 
Skin Sens. IA 
Aquatic Acute 1 
Aquatic Chronic 1 H361fd 
H335 
H319 
H317 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H361fd 
H335 
H319 
H317 
H410 M=1 
M=1 
607-712-00-6 dodemorph acetate; 4-
cyclododecyl-2,6-
dimethylmorpholin-4-ium 
acetate 250-778-2 31717-87-0 Repr. 2 
STOT RE 2 
Skin Corr. 1C 
Skin Sens. 1A 
Aquatic Chronic 1 H361d 
H373 (liver) 
H314 
H317 
H410 GHS08 
GHS05 
GHS07 
GHS09 
Dgr H361d 
H373 (liver) 
H314 
H317 
H410 EUH071 
M=1 
607-713-00-1 fenpyroximate (ISO); 
tert-butyl 4-[({(E)-[(l,3-
dimethyl-5-phenoxy-lH-
pyrazol-4-
yl)methylene]amino}oxy)methyl 
]benzoate -134098-61-6 Acute Tox. 3 
Acute Tox. 2 
Skin Sens. IB 
Aquatic Acute 1 
Aquatic Chronic 1 H301 
H330 
H317 
H400 
H410 GHS06 
GHS09 
Dgr H301 
H330 
H317 
H410 M=100 
M=1000 
607-714-00-7 triflusulfuron-methyl; methyl 
2-({[4-(dimethylamino)-6-(2,2,2-
trifluoroethoxy)-l,3,5-triazin-2-
y l]carbamoyl }sulfamoyl)-3-
methylbenzoate - 126535-15-7 Care. 2 
Aquatic Acute 1 
Aquatic Chronic 1 H351 
H400 
H410 GHS08 
GHS09 
Wng H351 
H410 M=100 
M=10 
607-715-00-2 bifenazate (ISO); 
isopropyl 2-(4-
methoxybiphenyl-3-
yl)hydrazinecarboxylate 442-820-5 149877-41-8 STOT RE 2 
Skin Sens. 1 
Aquatic Acute 1 
Aquatic Chronic 1 H373 
H317 
H400 
H410 GHS08 
GHS07 
GHS09 
Wng H373 
H317 
H410 M=1 
M=1 
613-319-00-0 imidazole 206-019-2 288-32-4 Repr. IB 
Acute Tox. 4 
Skin Corr. 1C H360D 
H302 
H314 GHS08 
GHS07 
GHS05 
Dgr H360D 
H302 
H314 
613-320-00-6 lenacil (ISO); 3-cyclohexyl-6,7-
dihydro-lH-
cyclopenta[d]pyrimidine-
2,4(3H,5H)-dione 218-499-0 2164-08-1 Care. 2 
Aquatic Acute 1 
Aquatic Chronic 1 H351 
H400 
H410 GHS08 
GHS09 
Wng H351 
H410 M=10 
M=10 
5 Index No International Chemical 
Identification EC No CAS No Classification Labelling Specific Cone. 
Limits, M-
factors Notes Index No International Chemical 
Identification EC No CAS No 
Hazard Class and 
Category Code(s) Hazard 
statement 
Code(s) Pictogram, 
Signal Word 
Code(s) Hazard 
statement 
Code(s) Suppl. Hazard 
statement 
Code(s) Specific Cone. 
Limits, M-
factors Notes 
616-213-00-2 mandipropamid (ISO); 2-(4-
ch lorophenyl )-N- í 2-[ 3-
methoxy-4-(prop-2-yn-l-
yloxy)phenyl]ethyl)-2-(prop-2-
yn-l-yloxy)acetamide - 374726-62-2 Aquatic Acute 1 
Aquatic Chronic 1 H400 
H410 GHS09 
Wng H410 M=1 
M=1 
616-214-00-8 metosulam (ISO); N-(2,6-
dichloro-3-methy lphenyl)-5,7 -
dimethoxy[l,2,4]triazolo[l,5-
a]pyrimidine-2-sulfonamide - 139528-85-1 Care. 2 
STOT RE 2 
Aquatic Acute 1 
Aquatic Chronic 1 H351 
H373 (eyes, 
kidneys) 
H400 
H410 GHS08 
GHS09 
Wng H351 
H373 
(eyes, 
kidneys) 
H410 M=1000 
M=100 
616-215-00-3 dimethenamid-P (ISO); 2-
chloro-N-(2,4-dimethyl-3-
thienyl)-N-[(2S)-
l-methoxypropan-2-
yljacetamide - 163515-14-8 Acute Tox. 4 
Skin Sens. 1 
Aquatic Acute 1 
Aquatic Chronic 1 H302 
H317 
H400 
H410 GHS07 
GHS09 
Wng H302 
H317 
H410 M=10 
M=10 
616-216-00-9 flonicamid (ISO); N-
(cyanomethyl)-4-
(trifluoromethyl)pyridine-3-
carboxamide - 158062-67-0 Acute Tox. 4 H302 GHS07 
Wng H302 
616-217-00-4 sulfoxailor (ISO); 
[methyl(oxo){l-[6-
(trifluoromethyl)-3-
py ridy ľ|ethyl}-/.ň-
sulfanylidene]cyanamide 946578-00-3 Acute Tox. 4 
Aquatic Acute 1 
Aquatic Chronic 1 H302 
H400 
H410 GHS07 
GHS09 
Wng H302 
H410 M=1 
M=1 
6 (2) Table 3.2 is amended as follows: 
(a) The entries corresponding to index numbers 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-
7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X, and 613-149-00-7 are replaced by the following 
corresponding entries: 
Index No International Chemical 
Identification EC No CAS No Classification Labelling Concentration Limits Notes 
007-004-00-1 nitric acid... % 231-714-2 7697-37-2 
O O 
í® O; C 
R: 8-35 
S: (l/2-)-26-28- 36/37/39-
45-63 O; R8: C > 65 % 
C;R35:C>20 % 
C; R34: 5 % < C < 20 % B 
015-003-00-2 calcium phosphide; tricalcium 
diphosphide 215-142-0 1305-99-3 F; R15/29 
T+; R26/28 
Xii; R21 
R32 
Xi; R38-41 
N; R50 F;T+;N 
R: 15/29-21-26/28-32-38-
41-50 
S:(l/2-)26-28-30-36/37/39-
43-45-60-61 N; R50: C > 0,25 % 
031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Repr. Cat. 2; R60 
Care. Cat. 2; R45 
Τ; R48/23 T 
R: 45-48/23-60 
S: 45-53 
E 
050-008-00-3 tributyltin compounds, with the 
exception of those specified 
elsewhere in this annex - -Repr. Cat. 2; R60-61 
Τ; R25-48/23/25 
Xn; R21 
Xi; R36/38 
N; R50-53 T; N 
R: 21-25-36/38-48/23/25-
50/53-60-61 
S: 45-53-60-61 T;R25:C>2,5 % 
Xn; R22: 0,25 % < C < 2,5 % 
Xn: R21: C > 1 % 
T; R48/23/25: C > 1 % 
Xn; R48/20/22: 0,25 % < C < 1 % 
Xi; R36/38: C > 1 % 
N; R50-53: C > 2,5 % 
N; R51-53: 0,25 % < C < 2,5 % 
R52-53: 0,025 % < C < 0,25 % A 
1 
603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 F; Ril 
Care. Cat. 3; R40 
Xn; R20/21/22 
Xi; R36/37/38 F; Xn 
R: 11-20/21/22-36/37/38-40-
S: (2-)9-16-29-36/37-46 
7 603-197-00-7 tebuconazole (ISO); 
l-(4-chlorophenyl)-4,4-dimethyl-3-
(l,2,4-triazol-l-ylmethyl)pentan-3-
ol 403-640-2 107534-96-3 Repr. Cat. 3; R63 
Xn; R22 
N; R50-53 Xn; N 
R: 22-50/53-63 
S: (2-)22-36/37-60-61 N; R50-53: C > 25 % 
N; R51-53: 2,5 % < C <25 % 
R52-53: 0,25 % < C < 2,5 % 
606-054-00-7 isoxaflutole (ISO); 
5-cyclopropyl-l,2-oxazol-4-yl α, a,a-
trifluoro-2-mesyl-/»-tolyl ketone - 141112-29-0 Repr. Cat. 3; R63 
N; R50-53 Xn; N 
R: 50/53-63 
S: (2-)36/37-60-61 N; R50-53: C > 2,5 % 
N; R51-53: 0,25 % < C < 2,5 % 
R52-53: 0,025 % < C < 0,25 % 
607-197-00-8 nonanoic acid 203-931-2 112-05-0 Xi; R36/38 
N; R51-53 Xi; N 
R: 36/38-51/53 
S: (2-)46-61 
613-042-00-5 imazalil (ISO); l-[2-(allyloxy)-2-
(2,4-dichlorophenyl)ethyl]-lff-
imidazole 252-615-0 35554-44-0 Care. Cat. 3; R40 
Xn; R20/22 
Xi; R41 
N; R51-53 Xn; N 
R: 20/22-40-41-51/53 
S: (2-)26-36/37/39-46-61 
613-057-00-7 dodemorph (ISO); 4-cyclododecyl-
2,6-dimethylmorphoiine 216-474-9 1593-77-7 Repr. Cat. 3; R63 
C; R34 
R43 
N; R50-53 C; N 
R: 34-43-50/53-63 
S: (l/2-)26-28-36/37/39-45-
60-61 C; R34: C > 10 % 
Xi; R36/37/38: 5 % < C < 10 % 
N; R50-53: C > 25 % 
N; R51-53: 2,5 % < C < 25 % 
R52-53: 0,25 % < C < 2,5 % 
613-133-00-X etridiazole (ISO); 5-ethoxy-3-
trichloromethyl- 1,2,4-thiadiazole 219-991-8 2593-15-9 Care. Cat. 3; R40 
Xn; R22 
R43 
N; R50-53 Xn; N 
R: 22-40-43-50/53 
S: (2-)36/37-46-60-61 N; R50-53: C > 25 % 
N; R51-53: 2,5 % < C < 25 % 
R52-53: 0,25 % < C < 2,5 % 
613-149-00-7 pyridaben (ISO); 
2-tert-butyl-5-(4-tert-
butylbenzylthio)-4-chloropyridazin-
3(2H)-one 405-700-3 96489-71-3 T; R23/25 
N; R50-53 T; N 
R: 23/25-50/53 
S: (l/2-)36/37-45-60-61 N; R50-53: C > 0,025 % 
N; R51-53: 0,0025 % < C < 0,025 % 
R52-53: 0,00025 % < C < 0,0025 % 
(b) The following entries are inserted in accordance with the order of the entries set out in Table 3.2: 
Index No International Chemical EC No CAS No Classification Labelling Concentration Limits Notes 
Identification 
8 Index No International Chemical 
Identification EC No CAS No Classification Labelling Concentration Limits Notes 
019-003-00-3 potassium (E,E)-hexa-2,4-dienoate 246-376-1 24634-61-5 Xi; R36 Xi 
R: 36 
S: (2-)25-46 
082-013-00-1 lead 231-100-4 7439-92-1 Repr. Cat. 1; R60-61 
R64 Τ 
R: 60-61-64 
S: 45-53 Repr. Cat. 1; R61: C > 0,03 % 
604-092-00-9 phenol, dodecyl-, branched [1]; 
phenol, 2-dodecyl-, branched; 
phenol, 3-dodecyl-, branched; 
phenol, 4-dodecyl-, branched; 
phenol, (tetrapropenyl) derivatives 
[2] 310-154-3 
[1] 
-[2] 121158-58-5 [1] 
74499-35-7 [2] C; R34 
N; R50-53 C; N 
R: 34-50/53-
S: (l/2-)-26-36/37/39-45-61 N; R50-53: C >2,5 % 
N; R51-53: 0,25 % < C < 2,5 % 
R52-53: 0,025 % < C < 0,25 % 
606-148-00-8 carvone (ISO); 
2-methyl-5-(prop-l-en-2-
yl)cyclohex-2-en-l-one; [1] 
d-carvone; (5S)-2-methyl-5-(prop-l-
en-2-yl)cyclohex-2-en-l-one; [2] 
1-carvone; (5R)-2-methyl-5-(prop-
l-en-2-yl)cyclohex-2-en-l-one [3] 202-759-5 
[1] 
218-827-2 
[2] 
229-352-5 
[3] 99-49-0 [1] 
2244-16-8 [2] 
6485-40-1 [3] R43 Xi 
R: 43 
S: (2-)24-37 
606-149-00-3 tembotrione (ISO); 2-{2-chloro-4-
(niethyIsult'onyl)-3-[(2,2,2-
trifluoroethoxy)methyl]benzoyl}cycl 
ohexane-1,3-dione 335104-84-2 Repr. Cat. 3; R63 
Xn; R48/22 
R43 
N; R50-53 Xn; N 
R: 43-48/22-50/53-63 
S: (2-)36/37-46-60-61 N; R50-53: C > 0,25 % 
N; R51-53: 0,025 % < C < 0,25 % 
R52-53: 0,0025 % < C < 0,025 % 
9 Index No International Chemical 
Identification EC No CAS Nū Classification Labelling Concentration Limits Notes 
607-707-00-9 fenoxaprop-P-ethyl (ISO); ethyl 
(2R)-2-{4-[(6-chloro-l,3-benzoxazol-
2-yl)oxy]phenoxy}propanoate -71283-80-2 Xn; R48/22 
R43 
N; R50-53 Xn; N 
R: 43-48/22-50/53 
S: (2-)24-37-46-60-61 N; R50-53: C >25 % 
N; R51-53:2,5 % < C < 25 % 
R52-53: 0,25 % < C < 2,5 % 
607-708-00-4 octanoic acid 204-677-5 124-07-2 C; R34 
N; R51-53 C; N 
R: 34-51/53 
S: (l/2-)26-36/37/39-45-61 
607-709-00-X decanoic acid 206-376-4 334-48-5 Xi; R36/38 
N; R51-53 Xi; N 
R: 36/38-51/53 
S: (2-)25-46-61 
607-710-00-5 1,2-Benzenedicarboxylic acid, 
dihexyl ester, branched and linear 271-093-5 68515-50-4 Repr. Cat. 2; R60-61 Τ 
R: 60-61 
S: 53-45 
607-711-00-0 spirotetramat (ISO); (5s,8s)-3-(2,5-
dimethylphenyl)-8-methoxy-2-oxo-
l-azaspiro[4,5]dec-3-en-4-yl ethyl 
carbonate - 203313-25-1 Repr. Cat. 3; R62-63 
Xi; R36/37 
R43 
N; R50-53 Χη; N 
R: 36/37-43-50/53-62-63 
S: (2-)36/37-60-61 Xi; R43: C > 0,1 % 
N; R50-53: C > 25 % 
N; R51-53: 2,5 % < C < 25 % 
R52-53: 0,25 % < C < 2,5 % 
607-712-00-6 dodemorph acetate; 4-cyclododecyl-
2,6-dimethylmorpholin-4-ium 
acetate 250-778-2 31717-87-0 Repr. Cat. 3; R63 
C; R34 
R43 
N; R51-53 C; N 
R: 34-43-51/53-63 
S: (l/2-)26-28-36/37/39-45-
61 C; R34: C > 10 % 
Xi: R36/37/38:5 % < C < 10 % 
607-713-00-1 fenpyroximate (ISO); 
tert-butyl 4-[({(E)-[(l,3-dimethyl-5-
phenoxy-lH-pyrazol-4-
yl)methylene]amino}oxy)methyl]be 
nzoate -134098-61-6 T+; R26 
Xn; R22 
R43 
N; R50-53 T+; N 
R: 22-26-43-50/53 
S: (l/2-)28-36/37-45-60-
61-63 N; R50-53: C > 0,25 % 
N; R51-53: 0,025 % < C < 0,25 % 
R52-53: 0,0025 % < C < 0,025 % 
607-714-00-7 triflusulfuron-methyl; methyl 2-
({[4-(dimethylamino)-6-(2,2,2-
trifIuoroethoxy)-l,3,5-triazin-2-
yl]carbamoyl}sulfamoyl)-3-
methylbenzoate - 126535-15-7 Care. Cat. 3; R40 
N; R50-53 Xn; N 
R: 40-50/53 
S: (2-)36/37-60-61 N; R50-53: C > 0,25 % 
N; R51-53: 0,025 % < C < 0,25 % 
R52-53: 0,0025 Vū < C < 0,025 % 
10 Index No International Chemical 
Identification EC No CAS No Classification Labelling Concentration Limits Notes 
607-715-00-2 bifenazate (ISO); 
isopropyl 2-(4-methoxybiphenyl-3-
yl)hydrazinecarboxylate 442-820-5 149877-41-8 R43 
N; R50-53 Xi; N 
R: 43-50/53 
S: (2-)24-37-60-61 N; R50-53: C >25 % 
N; R51-53: 2,5 % < C < 25 % 
R52-53: 0,25 % < C < 2,5 % 
613-319-00-0 imidazole 206-019-2 288-32-4 Repr. Cat 2; R61 
Xn; R22 
C; R34 T· C 
R: 22-34-61 
S: 53-45 
613-320-00-6 lenacil (ISO); 3-cyclohexy-6,7-
dihydro-lH-
cyclopenta[d]pyrimidine-
2,4(3H,5H)-dione 218-499-0 2164-08-1 Care. Cat. 3; R40 
N; R50-53 Xn; N 
R: 40-50/53 
S: (2-)36/37-60-61 N; R50-53: C > 2,5 % 
N; R51-53: 0,25 % < C < 2,5 % 
R52-53: 0,025 % < C < 0,25 % 
616-213-00-2 mandipropamid (ISO); 2-(4-
chl()rophenyO-iV-{2-[3-methoxy-4-
(prop-2-yn-l-yloxy)phenyl]ethyl}-2-
(prop-2-yn-l-yloxy)acetamide - 374726-62-2 N; R50-53 N 
R: 50/53 
S: 60-61 N; R50-53: C > 25 % 
N; R51-53: 2,5 % < C <25 % 
R52-53: 0,25 % < C < 2,5 % 
616-214-00-8 metosulam (ISO); N-(2,6-dichloro-
3-methylphenyl)-5,7-
dimethoxy[l,2,4]triazolo[l,5-
a]pyrimidine-2-sulfonamide - 139528-85-1 Care. Cat. 3; R40 
Xn; R48/22 
N; R50-53 Xn; N 
R: 40-48/22-50/53 
S: (2-)36/37-46-60-61 N; R50-53: C > 0,025 % 
N; R51-53: 0,0025 % < C < 0,025 % 
R52/53: 0,00025 % < C < 0,0025 % 
616-215-00-3 dimethenamid-P (ISO); 2-chloro-N-
(2,4-dimethyl-3-thienyl)-N-[(2S)-
l-methoxypropan-2-yl]acetamide - 163515-14-8 Xn; R22 
R43 
N; R50-53 Xn; N 
R: 22-43-50/53 
S: (2-)24-37-60-61 N; R50-53: C > 2,5 % 
N; R51-53: 0,25 % < C < 2,5 % 
R52-53: 0,025 % < C < 0,25 % 
616-216-00-9 flonicamid (ISO); iV-(cyanomethyl)-
4-(trifluoromethyl)pyridine-3-
carboxamide - 158062-67-0 Xn; R22 Xn 
R: 22 
S: (2-)46 
616-217-00-4 sulfoxaflor (ISO); [methyl(oxo){l-
[6-(trifluoromethyl)-3-
pyridyl]ethyl}-X6-
sulfanylidene]cyanamide 946578-00-3 Xn; R22 
N; R50-53 Xn; N 
R: 22-50/53 
S: (2-)60-61 N; R50-53: C >25% 
N; R51-53: 2,5% < C < 25% 
R52-53: 0,25%· < C < 2,5% 
11